argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
14 jun 2017 - 08:00
Statutory name
argenx SE
Title
argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas at the International Conference of Malignant Lymphoma (ICML)
Date last update: 12 April 2026